DANIEL MARK BEGEL

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry SANTA MONICA, CA NPI 1376609149

General Payments — all program years on this page

$5,017.69

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 179
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $511.91 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $484.6417
Education $27.271

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Alkermes, Inc. $229.006
Otsuka America Pharmaceutical, Inc. $107.204
Neurocrine BioSciences, Inc. $58.663
Lundbeck LLC $47.312
E.R. Squibb & Sons, L.L.C. $27.271
ITI, Inc. $21.291
ABBVIE INC. $21.181

By program year

Program yearAmountRecords
2018 $590.9621
2019 $995.5333
2020 $206.6310
2021 $570.2221
2022 $1,444.4450
2023 $698.0026
2024 $511.9118

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1101753909 E.R. Squibb & Sons, L.L.C. $27.27 10/31/2024 Education Undisputed 01/23/2026 View at CMS
1103300394 ABBVIE INC. $21.18 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118860197 Otsuka America Pharmaceutical, Inc. $26.60 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118860199 Otsuka America Pharmaceutical, Inc. $26.90 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118860201 Otsuka America Pharmaceutical, Inc. $29.81 08/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118860203 Otsuka America Pharmaceutical, Inc. $23.89 11/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120465129 Alkermes, Inc. $22.12 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120465131 Alkermes, Inc. $98.46 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120465133 Alkermes, Inc. $28.32 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120465135 Alkermes, Inc. $29.04 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120465137 Alkermes, Inc. $25.85 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120465139 Alkermes, Inc. $25.21 12/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143191763 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.29 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145896127 Lundbeck LLC $23.20 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145896129 Lundbeck LLC $24.11 06/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150824422 Neurocrine Biosciences, Inc. $30.95 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150876446 Neurocrine Biosciences, Inc. $14.46 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150879243 Neurocrine Biosciences, Inc. $13.25 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.